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Abstract
To be effective and sustain themselves over time, public- 
private  partnerships  must  make  evaluation  a  priority. 
Specifically, partnerships should evaluate 1) their infra-
structure, function, and processes; 2) programs designed to 
achieve their mission, goals, and objectives; and 3) changes 
in  health  and  social  status,  organizations,  systems,  and 
the  broader  community.  This  article  describes  how  to   
1) develop a comprehensive evaluation strategy based on 
partnership theory; 2) select short-term, intermediate, and 
long-term indicators to measure outcomes; 3) choose appro-
priate methods and tools; and 4) use evaluation results to 
provide accountability to stakeholders and improve part-
nership function and program implementation.
Introduction
Public-private partnerships fundamentally bring togeth-
er the expertise of the private and public sectors and allow 
each to do what it does best, so that products and services 
can be delivered efficiently and effectively. These partner-
ships also can help overcome organizational boundaries 
and allow parties to work together on a shared goal. For 
example,  even  though  collaborating  with  private-sector 
businesses  may  cause  tension  among  nonprofit  public-
sector partners, the businesses may bring new skills and 
funding to the partnership and enhance the partnership’s 
scope  of  influence.  An  illustration:  3  partnerships  were 
sponsored  by  a  national  association  of  health  plans  to 
improve  the  quality  of  diabetes  care  in  New  Mexico, 
Missouri, and New York. The main evaluation finding was 
that the competing health plans and local organizations 
established and sustained viable partnerships around a 
shared goal, despite significant challenges (1). The process 
of  evaluation  discovered  the  effects  of  these  vital  part-
nerships by answering the following questions: 1) What 
attributes and events resulted in competing organizations 
coming together? 2) What is necessary to sustain these 
partnerships? 3) What recommendations can help repli-
cate this approach for other chronic conditions in other 
communities? and 4) To what extent do local market char-
acteristics  and  structures  set partnership  direction  and 
influence success?
Evaluation  is  a  critical  task  for  any  partnership  and 
determines whether the organization and its activities are 
sustained over time. Effective evaluation provides ongo-
ing, systematic information that strengthens the partner-
ship during implementation and provides outcome data to 
assess the extent of change among participants or within 
systems (2).
Both the for-profit and nonprofit sectors place a high 
value on evaluation and regard it as a necessity rather 
than an enhancement. However, their underlying value 
systems and motivating factors may differ. For the non-
profit  sector,  partnership  evaluation  fulfills  underlying 
process goals, such as identifying new approaches, increas-
ing community awareness and support, informing policy 
decisions, and contributing to the understanding of what 
works (3). The public health issues have developed over 
time, and the public health community’s expectations are 
that desired evaluation outcomes may take years or even 
decades  to  accomplish.  Conversely,  the  for-profit  sector 
is  driven  by  increasing  its  market  share,  improving  its 
performance through continuous innovation, having good 
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financial  management  and  stability,  increasing  efficien-
cy,  increasing  customer  accountability  and  satisfaction, 
improving its access to government officials, and improv-
ing public relations. The time horizon for outcomes in the 
business sector is often a few months to 2 years. As the 
value systems of the for-profit and nonprofit sectors con-
verge, evaluation also will become more of a shared value. 
Partnering certainly can enable this process.
This article describes how evaluation is viewed by non-
profit and for-profit sectors, levels of partnership evalua-
tion, and a step-by-step model for evaluating partnerships. 
I conclude by presenting the challenges to evaluating part-
nerships and recommending solutions.
Views on Participatory Approaches to 
Evaluating Partnerships
Many partnership evaluations are based on collabora-
tive or participatory approaches according to who controls 
the process, who participates, and how much (4). These 
approaches are well suited to partnerships, although they 
have disadvantages (Appendix A) (5).
Participatory  approaches  to  evaluation  are  generally 
comfortable  and  customary  for  the  public  sector.  The 
private sector may not be as familiar with these types of 
evaluations nor as patient with the extra time and effort 
that it takes to be democratic and attentive to the needs 
of  all  partners,  priority  populations,  and  communities 
served. Discussing the extra benefits that result from such 
evaluations, such as better understanding and acceptance 
of findings that may improve performance, may enable for-
profit partners to be more open to these approaches and 
learn by participating in the evaluation process (6).
When  diverse  partners  work  together,  evaluation 
approaches and terms must be clarified. The private sec-
tor and the public sector may differ in their approaches to 
the evaluation or assessment process, the standards and 
methods they use to gather data, how they define terms, 
and the kinds of indicators they plan to measure.
For example, the VERB campaign used the best practices 
of private-sector marketing to children. The VERB brand 
created an emotional affinity between the product (physi-
cal activity) and the user (tween), and engaged tweens at 
key places and times when they might be both inactive 
and receptive to the brand (7). The public sector redefined 
its terms — education had to include persuasion, VERB 
was not a program but a brand, and pooling resources with 
the private sector allowed the public agency, the Centers 
for Disease Control and Prevention (CDC), to buy media 
time  and  the  talents  of  marketing  experts.  The  agency 
also adjusted its concepts of performance measures and 
outcomes to meet both private investors’ needs and public 
health’s goals.
Coming to consensus on definition of terms, methods, 
and  measures  is  a  crucial  step  in  building  trust  when 
beginning  a  partnership  evaluation.  Although  public 
health professionals may feel comfortable using the terms 
process, impact, and outcome measures, using the terms 
short-term,  intermediate,  and  long-term  indicators  is 
more descriptive and avoids confusion when working with 
partners from diverse professional backgrounds. Different 
evaluation  terms  that  the  for-profit  and  nonprofit  sec-
tors may use in a public-private partnership are listed in 
Table 1.
Levels of Partnership Evaluation
In public-private partnerships, evaluation may measure 
1)  processes  that  sustain  and  renew  partnership  infra-
structure and function; 2) programs intended to accom-
plish targeted activities or those that work directly toward 
the partnership’s goals; and 3) changes in health status 
or the community. Appendix B details these 3 levels and 
sample measures for each. The aim of every partnership 
should be to evaluate something in each level. Conducting 
a member survey to assess satisfaction with how the orga-
nization functions (level 1), evaluating 1 program or activ-
ity that the partnership conducts (level 2), and collecting 
extant data on key health indicators (level 3) are reason-
able expectations for an annual evaluation plan.
Steps in Partnership Evaluation
Many practical frameworks and models exist that can 
help partnerships develop evaluation plans, but the focus 
here  is  on  the  Framework  for  Program  Evaluation  in 
Public  Health  (8,9).  The  framework  guides  its  users  in 
selecting  evaluation  strategies  that  are  useful,  feasible, 
ethical, and accurate — its 6 steps help increase under-
standing of a partnership’s context as well as its outcomes. VOLUME 6: NO. 2
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The steps have been refined and described below to apply 
to partnership evaluation.
Step 1: Engage the stakeholders
Engaging  stakeholders  means  fostering  participation 
and power sharing among people invested in the evalu-
ation  and  its  findings.  Stakeholders  include  1)  those 
involved  in  program  operations  (eg,  partners,  public 
relations  professionals,  lawyers,  sponsors,  funders,  col-
laborators,  administrators,  managers,  business  owners, 
staff),  2)  those  served  or  affected  by  the  program  (eg, 
clients, customers, families, neighborhood organizations, 
academic institutions, elected officials, advocacy groups, 
professional  associations,  opponents),  and  3)  primary 
users of the evaluation. Stakeholders must understand the 
organizational structure, history, and goals of the partner-
ship and how politics affect program implementation and 
impact. This understanding can be attained by creating an 
environment where stakeholders discuss their values, phi-
losophies and assumptions, and capabilities. Stakeholders 
may 1) provide resources for evaluation such as staff and 
in-kind supplies, 2) clarify partnership goals and objec-
tives,  3)  identify  and  prioritize  evaluation  questions,  4) 
develop and pilot evaluation methods and tools, 5) collect 
data, and 6) interpret and report results (10).
Stakeholders’ needs, concerns, and demands for specific 
outcomes differ widely, even though they may agree with 
the  partnership’s  goals  and  objectives.  To  motivate  the 
stakeholders to participate in the partnership and its eval-
uation, data could be gathered from them about what they 
need the evaluation to measure. A sample set of criteria is 
included in Table 2 (11).
Step 2: Describe the partnership
This description should focus on the purpose, goals, objec-
tives, resources, current and planned activities, expected 
outcomes, stage of development, and environmental con-
text of the partnership. In a public-private partnership, 
objectives are based on compromise among partners with 
different  political,  social,  and  economic  aims.  Divergent 
interests concerning actions and expected impacts must 
be taken into account (11). Developing a logic model is 1 
way to help stakeholders clarify the partnership’s ratio-
nale, strategies, and conditions. It serves as a road map 
of the program, prioritizes the sequence of activities, sum-
marizes expected change by linking processes to eventual 
outcomes,  shows  how  partnership  programs  are  linked 
to other ongoing efforts, and displays the infrastructure 
needed to support the partnership (9). An effective logic 
model  will  be  refined  and  changed  many  times,  as  the 
partners learn about how and why the partnership works. 
A sample logic model for a state partnership is in CDC’s 
National Heart Disease and Stroke Prevention Program’s 
Evaluation Guide (10).
Partnerships develop in stages: 1) formation — initial 
building of the organization, 2) implementation — strate-
gic planning and conducting of activities to address goals, 
3)  maintenance  —  sustaining  activities  until  goals  are 
accomplished, and 4) institutionalization — collaborative 
attainment of goals in permanent structures within the 
community (12,13). The current stage of the partnership 
should be assessed to determine the proper focus for evalu-
ation (8). For example, evaluation activities should focus 
on identifying and recruiting partners if the partnership is 
in the formation stage; communication and decision mak-
ing in the maintenance stage; and community changes in 
the institutionalization stage. A comprehensive evaluation 
of a mature partnership includes measures at each stage.
Step 3: Focus the evaluation design
The evaluation should focus on issues of greatest concern 
to stakeholders, while efficiently using time and resources. 
A written plan that summarizes evaluation goals and pro-
cedures and outlines the stakeholders’ roles and respon-
sibilities is essential. The plan should include evaluation 
questions and practical methods for sampling, data col-
lection,  data  analysis,  and  interpretation.  Stakeholders 
can help prioritize the questions to determine which are 
critical, are likely to improve the partnership, and can be 
answered with available resources. Questions may include 
the following:
• What should the partnership accomplish and how will it 
be demonstrated?
• What activities will the partnership undertake to accom-
plish its goals?
• What factors might help or hinder the accomplishment 
of its goals?
• Who are the partners (number, diversity, and participa-
tion levels)?
• How do partners work together?
• What partnership outcomes should be measured?VOLUME 6: NO. 2
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The  evaluation  design  is  linked  to  the  priority  ques-
tions, and the choice of design has implications for what 
data will be collected and how. A pretest-posttest design 
uses  a  comparison  group,  measures  the  partnership  on 
given parameters before and after it implements planned 
improvement strategies, or both. A case study design is 
used to study the partnership’s context, history, structure, 
and function. Case studies usually rely on multiple sources 
of information such as observations, interviews, audiovisu-
al material, documents, and reports. Appendix C provides 
a sample evaluation plan for partnerships (14).
Step 4: Gather credible evidence
After deciding on the evaluation questions and design, 
the partnership must decide what data it needs to answer 
the questions, where and how the data can be obtained, 
and how the data should be analyzed and used. Adequate 
data may be available and easily accessed, or new data 
may have to be collected. Evaluation data should provide 
a well-rounded picture of the partnership and its programs 
so stakeholders can perceive the results as believable and 
relevant.  Integrating  qualitative  and  quantitative  data 
increases the likelihood that data will be balanced and 
accepted by all stakeholders (15).
For each evaluation question, at least 1 indicator or data 
point must be defined and tracked. Examples of indicators 
for partnerships might include measures of 1) partnership 
effectiveness  (eg,  participation  in  meetings  and  activi-
ties, usefulness of partnership structures), 2) partnership 
activities (eg, participation rate, completion of state plan 
objectives),  and  3)  partnership  effects  (eg,  number  of 
policies or practices that were amended or adopted, health 
status changes). Practitioners and researchers have sum-
marized measures that document changes in partnership 
knowledge, attitudes, practices, community environment, 
policies, and health status (2,16,17).
For  each  evaluation  question  and  indicator,  sources 
of  data  must  be  identified.  Data  from  documents,  key 
informant interviews, meeting observations, member sur-
veys, and focus groups provide different perspectives of 
the  partnership  and  enhance  the  comprehensiveness 
and credibility of the evaluation. Census data (including 
economic  data  and  demographics),  health  survey  data 
(eg, Behavioral Risk Factor Surveillance System survey 
results), or behavioral outcome data (eg, emergency medi-
cal transports, hospital admissions) represent likely data 
sets that partnerships may use to assess health and qual-
ity of life status. A rule of thumb is to collect only data that 
will be used and to use all data collected.
In deciding what instruments to use, partnerships may 
develop their own questionnaires or interview frameworks, 
use  validated  and  reliable  tools,  or  modify  an  existing 
tool to fit their priority population(s), community culture, 
and  issues.  Coalitions  and  Partnerships  in  Community 
Health (2) lists tools and resources for these evaluations. 
Stakeholders should develop clear procedures for gathering, 
analyzing, and interpreting data, and training staff, part-
nership members, and volunteers to collect quality data.
Step 5: Justify conclusions
After designing an evaluation, data must be collected, 
described,  analyzed,  and  synthesized  to  summarize  the 
findings, then interpreted to decide what it means in the 
context  of  the  partnership.  Investing  enough  time  and 
resources in analysis and interpretation is critical because 
this is when decisions are made and actions are taken. 
Once data are collected, they are returned to stakehold-
ers  for  reflection  and  verification.  Stakeholders  should 
look beyond the raw data to ask what the results mean, 
what led to the findings, and whether they are significant. 
Each partner has different criteria for judging success and 
weighs  them  differently;  using  multirater  analysis  may 
help (11). Conclusions are justified and will be used with 
confidence when they are supported by data, consistent 
with the agreed-on values of the stakeholders, and linked 
to recommended actions.
Step 6: Ensure use and share lessons learned
The partnership should provide continuous feedback to 
stakeholders  regarding  interim  findings  to  ensure  that 
evaluation  conclusions  lead  to  appropriate  decisions  or 
actions.  Stakeholders  are  more  likely  to  use  evaluation 
results if they feel they own the evaluation process and if 
they function cohesively as a team. During each planning 
and implementation step, stakeholders should discuss the 
best  ways  to  communicate  evaluation  findings  and  use 
them. Frequent communication will increase the commit-
ment to act on the results and refine the evaluation design, 
questions, methods, and interpretations. Having a positive 
experience  with  evaluation  changes  participants’  atti-
tudes; they begin to base decisions on judgments instead 
of assumptions (6).VOLUME 6: NO. 2
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The Challenges of Evaluating Partnerships
Researchers  agree  that  partnerships  are  difficult  to 
evaluate. Measuring system-level changes is more difficult 
than evaluating program outcomes because multiple levels 
and community readiness must be considered (18). Other 
practical and methodologic issues include the following:
• The  partnership’s  planning  process  does  not  include 
evaluation. Resources are often inadequate or are more 
likely to be spent on interventions. Because evaluation 
is costly in time and resources, the partnership is not 
always committed to do it. If evaluation is supported, 
staff are motivated to make partnership programs look 
effective to maintain funding or jobs. Evaluation may 
not be based on a solid logic model or theory, and part-
nerships may fail to find the right evaluators or tools for 
evaluating partnership processes and outcomes (19).
• Each partnership is unique. Partnerships are embed-
ded within communities and responsive to their cul-
tural contexts. For this reason, they tend to be unique, 
difficult  to  replicate,  and  unrepresentative  of  other 
partnerships, even those that address similar issues.
• The design and methods of the evaluation can make 
generalization  difficult.  Establishing  and  measuring 
outcomes, controlling extraneous variables that inter-
act with outcomes, accounting for secular trends over 
the  partnership’s  development,  and  addressing  the 
political realities to satisfy funders make it challeng-
ing  to  detect  systems-level  change  (20).  Extraneous 
variables (eg, new government programs, changes in 
funding streams) are difficult to control and may inter-
act with each other or influence outcomes by changing 
how programs are implemented. Partnerships may not 
identify outcome measures or link them to appropriate 
intermediate outcomes. Even when comparable long-
term outcomes are measured across sites, baseline data 
may not be available. Finally, distinguishing between 
cause  and  effect  or  the  percentage  of  the  outcome 
that can be attributed to each partnership activity is   
difficult (20-22).
Recommendations to Improve Partnership 
Evaluation
Partnerships  may  be  the  best  vehicles  available  to 
address  the  chronic  diseases  of  our  time,  so  evaluation 
methods continuously need to be refined. The following 
are  proposed  solutions  to  partnership  evaluation  issues 
(2,3,20,23-27):
•	Use innovative, qualitative evaluation methods. Rely on 
qualitative methods that represent the community and 
try to figure out how partnerships make a difference. 
Innovative methods need to be developed to address the 
dynamic nature of partnerships (25).
• Focus  on  evaluating  practice-proven  strategies  and 
measurable outcomes. Partnerships are best suited to 
assessment and priority setting rather than implement-
ing  projects  (4).  Evaluators  must  concern  themselves 
with short-term, immediate, and long-term effects of the 
partnership. In addition to health and social outcomes, 
evaluation  should  focus  on  how  partnerships  build 
capacity  by  improving  outcomes  related  to  participa-
tion, leadership, networks, skills, resources, and sense 
of community (28). Similarly, evaluators may determine 
whether a partnership is on track to become empowered 
and sustained by noting outcomes such as community 
infrastructure improvements, economic enhancements, 
educational opportunities, and policy changes (29).
• Provide  needed  training  and  technical  assistance. 
Appropriate training, technical assistance, and resources 
for conducting effective evaluations should be available 
to partnerships, so they learn how to translate evalua-
tion results into actionable tasks.
• Help partnerships “begin where they are.” Most partner-
ships view evaluation as a formidable task and choose 
not  to  evaluate.  They  are  overwhelmed  by  technical 
tasks, time and financial costs, and concerns that they 
might not “measure up.” Partnerships should be encour-
aged to start small and evaluate something. They might 
choose to evaluate 1 aspect of the partnership from each 
of 3 levels (short-term, intermediate, and long-term) as 
a starting point. Existing data can be evaluated with 
little or no cost. As examples, partner diversity can be 
determined by assessing the roster; attendance patterns 
can be derived from the meeting minutes. As confidence 
and skills grow, partners may be encouraged to engage 
in new and more complex evaluation tasks.
Conclusion
Public-private partnerships can be powerful agents for 
preventing and managing chronic disease. However, such 
partnerships become more complex as the public sector 
works  more  closely  with  private-sector  partners.  The   VOLUME 6: NO. 2
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following issues must be considered in developing evalua-
tions that lead to improvements in partnerships and their 
programs and services:
• What common evaluation criteria can be agreed on (eg, 
frequency of evaluation)?
• How  can  the  environment  for  public-private  partner-
ships be assessed?
• How can partnerships obtain adequate resources to con-
duct effective evaluations?
• What are the roles of various stakeholders in the evalu-
ation?  How  can  technical  and  evaluation  capacity  be 
fostered?
• How can evaluation be built into the framework of the 
partnership?
• Can existing tools and methods be adapted to meet pub-
lic and private partners’ needs?
How well these issues are addressed will help determine 
the effectiveness of partnership evaluations. Evaluations 
that  meet  stakeholder  needs  and  focus  on  mutually 
acceptable and measurable systems-level outcomes will 
make partnership support and sustainability more likely 
in the end.
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Tables
Table 1. Evaluation Terms Commonly Used by Nonprofit 
(Public Sector) and For-Profit (Private Sector) Partners
Nonprofit (Public Sector) For-Profit (Private Sector)
Evaluation Assessment or monitoring
Program effectiveness Efficiency or cost-effectiveness
Program or intervention Product
Quality assurance Quality improvement
Outcomes Results or benchmarks
Process measures Short-term indicators or benchmarks
Impact measures Intermediate indicators or benchmarks
Outcome measures Long-term indicators or bottom line
Priority populations Targets or market segments
Table 2. Partnership Sectors and Relevant Evaluation 
Parametersa
Partner Sector Evaluation Criteria
Economic/business 
partners
Job creation
Employment and volunteer opportunities
Personal income level
Human services 
partners
Access to essential services (eg, housing, sanita-
tion, clean water, adequate nutrition)
Health partners Population health status (eg, morbidity and mortal-
ity statistics)
Health care access and treatment
Education partners School enrollment
School dropout rates
Literacy rates
Human rights 
partners
Negative freedoms from forced labor; judicial kill-
ings; unlawful detention; or torture, coercion, and 
corporal punishment
Positive freedoms to associate and assemble 
peacefully, organize political opposition and trade 
unions, and speak freely and participate in public 
debates
Government and 
political partners
Administrative capacity or organizational develop-
ment and strengthening to improve service delivery
Capacity to plan, implement projects, and act as 
pressure group to gain influence
Financial and human resources
 
a Source: Toulemond et al ().VOLUME 6: NO. 2
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Appendices
Appendix A. Advantages and Disadvantages of 
Participatory Evaluation of Public-Private Partnerships
Advantages
•	 Engages and empowers multiple stakeholders.
•	 Improves program implementation and outcomes.
•	 Uses systematic, multidisciplinary approaches to problem solving.
•	 Is based on local community circumstances and issues.
•	 Is flexible; adapts to evolving needs of organization and its projects.
•	 Recognizes power of participation and works to enhance or sustain it 
through group dialogue, training, and action.
•	 Provides broader feedback of higher quality.
•	 Provides better understanding and acceptance of findings.
•	 Provides practical recommendations and reports that increase likelihood 
that evaluation results will be used.
Disadvantages
•	 Participants’ motivation, commitment, and skills vary.
•	 Extra resources are needed to build relationships and train partners.
•	 Highly technical reports are not usually produced.
•	 Extra time is needed to fully involve members and obtain needed  
feedback.
•	 Some rigor may be lost initially.
Appendix B. Partnership Evaluation Levels and Measures
Level 1 — Partnership infrastructure, function, and processes
In the early stages, partnerships create mission statements, set up work 
groups, conduct assessments, and develop action plans. To sustain 
momentum, a partnership has to recruit and orient new members, train 
leaders, prepare members to assume leadership when turnover occurs, 
address and resolve conflict, engage in public relations, raise funds, and 
celebrate its accomplishments. Process evaluation will document what was 
done, how people were recruited and engaged in partnership efforts, and 
whether the partnership is functioning optimally or as originally intended. 
This type of evaluation essentially assesses the short-term outcomes of 
the partnership’s development as an organization. Collecting and analyzing 
annual reports, attendance records, contribution records, meeting minutes, 
activity logs, and surveys that measure members’ levels of satisfaction, 
commitment, and participation are methods and measures that may be 
used to document partnership structure and function.
Level  measures are short-term outcome measures used to document 
changes in the number and type of partners, the perceptions or skills of 
staff and members, or the mission or direction of the partnership.
•	 Member	representation. Representation of organizational partners by 
community sector, diversity of racial and ethnic groups, and members’ 
perceptions of representativeness.
•	 Member	skills	and	experience. Number of years worked on issue, 
skills and expertise related to issue, collaboration and partnership man-
agement skills, and other strengths.
•	 Recruitment. Number of community sectors represented, average 
length of membership, success in recruiting new members, and steps 
taken to ensure representativeness.
•	 Participation. Length of service; level of participation over time; average 
meeting attendance; number of meetings and activities attended; drop-
out and retention rates; number of hours spent per month on partner-
ship work; service on committees or in leadership roles; voluntary, paid, 
or consultant roles; types of activities engaged in; extent of personal and 
organizational contributions; and effective use of member abilities.
•	 Role	clarity. Knowledge about partnership mission, structure, and oper-
ations, and whether role perception of members matches that of staff 
about partnership’s involvement in developing action plans, budgets, and 
plans and objectives.
•	 Costs	and	benefits	of	participation. Costs include personal or part-
nership/group difficulties such as personal, social, material, and pur-
posive costs. Benefits include personal, social, purposive, and material 
benefits, and extent to which participation changed members’ knowl-
edge, beliefs, and skills. Overall assessment of benefits versus costs of 
participation also can be made.
•	 Satisfaction. Global satisfaction with work of partnership and with per-
sonal involvement, team’s work and plan, specific aspects of group func-
tion and achievement, and progress and strength of organization.
•	 Commitment. Strength of member commitment to partnership, sense of 
pride, endorsement of mission and efforts, and caring about its future.
•	 Collaboration. Increased cooperation, joint planning of activities, net-
working, and information exchange. Determining factors include sharing 
a vision, political climate, history, understanding of goals and objectives, 
roles and responsibilities, decision-making processes, connectedness, 
conflict management, leadership, plans, policies, relationships, trust, 
community development, communication, resources, and evaluation.
•	 Sense	of	ownership. Staff and partners’ commitment, sense of pride, 
and concern for partnership’s future; perceived influence on organiza-
tional processes, goals, and structure.
•	 Sense	of	community. Feelings of connection, support, and collective 
problem solving; perceived severity of community problems.
•	 Expectations. Expectation that partnership will have effect on health 
issue, partners will engage in activities, planned activities will be fully 
implemented, and group will accomplish planned outcomes.
•	 Perceived	effectiveness. Perception that partnership is effective in its 
activities, fund raising, coordination, training, goal setting, communica-
tion, public relations, and evaluation.
•	 Leadership. Leader support style (egalitarian, empowering, encourag-
ing), decision-making style and control (democratic or authoritarian), 
competence, effectiveness in articulating vision, decision making, 
incentive management, conflict management; defining roles, facilitating 
meetings, nurturing collaborative group commitment and achievement, 
providing guidance, support, and feedback.
•	 Staff	performance. Staff time devoted to partnership; staff expertise, 
priorities, interest, availability and turnover; transfer of knowledge and 
skills from staff to members; staff relationship with members; efficiency 
in managing partnership process and operating procedures; staff ability 
to guide and support partnership; staff shares responsibility with mem-VOLUME 6: NO. 2
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bers; and staff costs and benefits of maintaining partnership.
•	 Formal	organizational	structure	and	planning	products. Level of 
formality and complexity of partnership’s structure and operation, as 
measured by assessing presence and quality of bylaws, agendas, min-
utes, and action plans; functioning steering committee and work groups, 
planning mechanisms, memoranda of agreement, and procedures for 
leadership stability and renewal; member orientation and training, com-
munication, decision making, and conflict resolution.
•	 Task	focus	and	meeting	effectiveness. Task focus of meetings, order 
and organization of group, meeting effectiveness and efficiency, formal 
structures and accomplishment of tasks by stage of development.
•	 Organizational	climate. Involvement, inclusion and task focus, orga-
nizational barriers, satisfaction level and commitment, cohesion, leader 
support and control, expression, independence, task orientation, self-
discovery, anger and aggression, order and organization, and innovation 
within the partnership.
•	 Group	relationships. Partnership relations or nature, quality and fre-
quency of interactions; trust, conflict management, team work, use of 
talents, and recognition; and comfort and satisfaction of being heard 
and valued.
•	 Communication. Quality, frequency, and productivity of member-staff 
and member-member communications, and use of various communica-
tion methods.
•	 Conflict. Amount of tension in partnership caused by opinion differ-
ences, personality clashes, hidden agendas, and power struggles.
•	 Decision	making. Extent of influence that individuals, group, staff, 
and leaders have in determining partnership’s policies and actions, and 
member inclusion and involvement in group processes.
•	 Resources. Personnel, sponsorships, contracts, grants, funds, and in-
kind donations mobilized by partnership and whether they are sufficient 
and effectively used.
•	 Plan	quality. Evaluation of partnership’s action or state plan and plan-
ning process — includes scope, comprehensiveness, clarity, effective-
ness, and quality of plans. Specific measures include clear and achiev-
able mission, goals, objectives and tasks, defined responsibilities, and 
use of community resources.
•	 General	functioning. Partnership’s capacity for group functioning and 
effective action related to community ownership, organizational effective-
ness, group accomplishments, relationships between partners, other 
organizations, and community. Includes activities and factors involved in 
recruitment, goals, leadership, responsibilities, decision making, building 
trust, fund raising, making linkages and referrals, securing resources, 
strengthening policy or regulations, managing negotiations, cultural  
competence, planning, recruitment, training, evaluating, and building  
capacity.
Level 2 — Partnership programs and interventions
To achieve program outcomes, partnership activities (eg, training, advocacy, 
education programs) must be fully implemented and reach priority popula-
tions. For example, a partnership to prevent asthma might develop cur-
ricula, public awareness campaigns, or advocate changes in clean indoor 
air policies. Successful implementation depends on available resources, a 
time-phased action plan, and a supportive environment. This level of evalu-
ation is conducted not only to prove that programs work but also to improve 
them. Adaptations of interventions that have been previously evaluated or 
accepted as promising practices increase the likelihood that interventions 
will result in systems-level change, and ultimately, desired health and social 
outcomes. Intermediate outcomes that are associated with changes in the 
priority population, the partnership, or the state’s capacity to achieve long-
term outcomes should be measured. For example, observations of clinic 
functioning, home visit logs, media reach reports, and event attendance 
forms provide short-term evidence of whether programs are implemented 
effectively and with fidelity. Patient record reviews help determine whether 
medical personnel adopt practice guidelines, and legislative records provide 
evidence of when and how proposed policies were introduced or passed.
Level 2 measures are short-term and intermediate outcomes that focus 
on activities and programs that the partnership accomplishes; the people, 
organizations, and groups it serves and affects; and the scope of the efforts 
it initiates. These measures include accomplishment of program outcomes 
such as changes in knowledge, attitudes, and behaviors.
•	 Implementation. Overall assessment of extent of implementation of 
action plan, type and number of completed activities, resources gener-
ated, and capitalization of opportunities outside of plan.
•	 Media	coverage. Coverage of partnership events or issues by radio, 
television, and print media (number of radio spots, number of news out-
lets featuring the advertisements, amount of time recorded, or inches of 
print).
•	 New	or	modified	services	or	programs. Classes, programs, work-
shops, publications, services, or communications provided by partnership 
and members.
•	 Community	actions	taken. Actions taken to encourage community 
change, such as promoting multiple administrations of vaccines or creat-
ing a safety checklist to monitor condition of playground equipment.
•	 New	or	modified	policies. Policies promoted by partnership and its 
members, such as restricting sales of cigarettes to minors or enacting 
smoke-free restaurant ordinance.
•	 New	or	modified	practices. Practices promoted by partnership and its 
members, such as following standard pathway to improve emergency 
department treatment of childhood asthma.
Level 3 — Health and systems change outcomes
For partners and funders, the bottom line is whether the partnership 
achieves its ultimate, long-term goals. Systems change does not hap-
pen quickly, and many outcomes are difficult to measure using traditional 
quantitative methods. Participatory and qualitative evaluation methods 
increase understanding about how and why community-based initiatives 
work. Epidemiologic data will indicate whether health status indicators have 
changed, but key informants can identify the partnership programs that are 
institutionalized within their organizations.
Level  measures focus on ultimate partnership outcomes beyond pro-
grammatic activities — long-term outcomes such as changes in health 
status, quality of care, effectiveness of community institutions, and over-
all changes in the community’s capacity and competence to deal with 
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•	 Community	capacity. Community’s ability to plan, solve problems, 
implement programs, network, collaborate, conduct research, and evalu-
ate its work.
•	 Organizational	viability. Assessment of whether groups continue to 
meet and function, level of institutionalization of programs, organizational 
empowerment, and community competence.
•	 Health	status	indicators. Ultimate changes that relate to partnership’s 
mission. A chronic disease prevention partnership would expect reduced 
rates of cardiovascular disease and cancer; a partnership focused on 
asthma management would expect reduced incidence of asthma exacer-
bations and hospitalizations and emergency department admissions due 
to asthma.
Appendix C. Partnership Evaluation Questions and Methods
Questions (Evaluation Measure)
Type of Data Collection Type of Design
Survey/ 
Scale
Structured 
Interview
Self-
Report/ 
Log
Direct 
Obser-
vation
Archival 
Records
Case 
Study
Pretest-
Posttest 
Control 
Group
Time 
Series
Planning and implementation issues (descriptive and process measures)
Who participates? (demographic data)   X X     X    
Why do partners drop out? (partners’ reasons for dropping 
out)
  X X     X    
Are different activities generated? (type and frequency of 
activities)
      X X X    
Assessing attainment of objectives (outcome measures)
How many participate? (no. of partners)     X X X X   X
How many hours are partners involved? (no. of hours by 
activity)
    X X X X   X
How many people are trained? (no. of partners per 
workshop/retreat)
    X X X X   X
Impact on participants
How do attitudes and behavior change by participating in 
program? (changes in attitude and behavior)
X X X X X   X X
Does participation affect incidence, prevalence, or man-
agement of disease? (incidence/prevalence of asthma, 
diabetes, heart disease, and stroke)
X X     X   X  
Are participants satisfied with experience? (satisfaction 
ratings)
X         X    
Impact on community
What resulted from program? (changes in programs, poli-
cies, and practices of partner organizations)
X X X X X     X
Do partnership benefits outweigh costs? (cost-benefit 
data)
  X X   X X    
Are community members satisfied with partnership and 
services they provide? (beneficiaries and community 
members/satisfaction ratings)
X         X    
 
a Adapted from Francisco et al ().